Pacemaker Status and 5‐Year Mortality After TAVI : A Sex‐Specific Analysis
European Journal of Clinical Investigation · 2026-07 · 56 (7)
DOI: 10.1111/eci.70242 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Investigation, online erschienen am 02.07.2026. Verfasst von Cecilia Veraar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine 3, University Hospital St. Pölten - NOE LGA, Karl Landsteiner University, St. Pölten, Austria. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Pacemaker, Artificial, Aortic Valve Stenosis. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Sex‐specific differences regarding the prognostic impact of permanent pacemaker (PM) implantation after transcatheter aortic valve implantation (TAVI) remain largely unexplored.
Objectives
To investigate sex‐specific associations between pre‐existing and new post‐procedural PM implantation and short‐ and long‐term mortality after TAVI.
Methods
This post hoc analysis of a prospective registry included consecutive patients who underwent TAVI between 2016 and 2020. Patients were stratified by sex and assigned to three groups: no PM, pre‐existing PM (pre‐PM) and PM implantation within 30 days of TAVI (post‐PM). The primary endpoint was 5‐year all‐cause mortality; the secondary endpoint was 30‐day mortality. Sex‐stratified multivariable proportional hazards models and Kaplan–Meier analyses were performed.
Results
Among 1114 patients (81 ± 5 years, 49.8% female), women more frequently had no PM (80.2% vs. 70.8%, p < 0.001) and less often had a pre‐existing PM (7.0% vs. 14.5%, p < 0.001). Post‐PM rates were similar between sexes (12.8% vs. 14.7%, p = 0.172). Thirty‐day survival differed by PM status only in women, with worse outcomes in the post‐PM group (log‐rank p = 0.033), whereas no difference was observed in men ( p = 0.542). Five‐year survival did not differ by PM status among women ( p = 0.572) but differed significantly among men ( p < 0.001), with the lowest survival in men with pre‐PM.
Conclusion
Post‐procedural PM implantation was associated with higher 30‐day mortality in women, whereas pre‐existing PM predicted reduced 5‐year survival in men, supporting sex‐specific risk assessment before and after TAVI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine 3, University Hospital St. Pölten - NOE LGA, Karl Landsteiner University, St. Pölten, Austria.
- Department of Internal Medicine II, Paracelsus Medical University of Salzburg, Salzburg, Austria.
ORCID-Profile: Cecilia Veraar
Zitieren
APA
Veraar, C., Lamm, G., Will, M., Hammerer, M., Granner, M., Merl, L., Schwarz, K., & Mascherbauer, J. (2026). Pacemaker Status and 5‐Year Mortality After TAVI : A Sex‐Specific Analysis. European Journal of Clinical Investigation, 56(7). https://doi.org/10.1111/eci.70242
Vancouver
Veraar C, Lamm G, Will M, Hammerer M, Granner M, Merl L, et al. Pacemaker Status and 5‐Year Mortality After TAVI : A Sex‐Specific Analysis. European Journal of Clinical Investigation. 2026;56(7). doi:10.1111/eci.70242
BibTeX
@article{Veraar2026,
author = {Veraar, Cecilia and Lamm, Gudrun and Will, Maximilian and Hammerer, Matthias and Granner, Matthias and Merl, Lion and Schwarz, Konstantin and Mascherbauer, Julia},
title = {Pacemaker Status and 5‐Year Mortality After TAVI : A Sex‐Specific Analysis},
journal = {European Journal of Clinical Investigation},
year = {2026},
volume = {56},
number = {7},
doi = {10.1111/eci.70242}
}
EUVIMED